Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 181 clinical trials
Escitalopram for Agitation in Alzheimer's Disease

The purpose of this study is to evaluate the safety and efficacy of escitalopram for agitation in Alzheimer's dementia.

alzheimer's disease
agitation
antipsychotics
mental state examination
citalopram
Sheppard Pratt Health System
 (9.3 away) Contact site
  • 282 views
  • 15 May, 2021
  • +32 other locations
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

This phase II Pediatric MATCH trial studies how well vemurafenib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with BRAF V600 mutations that have spread to other places in the body (advanced) and have come back (recurrent) or do not respond to treatment (refractory). Vemurafenib may …

graft versus host disease
radiopharmaceutical therapy
pegfilgrastim
cancer chemotherapy
vemurafenib
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 236 views
  • 22 Aug, 2021
  • +75 other locations
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

This phase II Pediatric MATCH trial studies how well larotrectinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with NTRK fusions that have spread to other places in the body and have come back or do not respond to treatment. Larotrectinib may stop the growth of …

graft versus host disease
match treatment
cancer therapy
hematopoietic growth factors
radiopharmaceutical therapy
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 352 views
  • 12 Sep, 2021
  • +83 other locations
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer

This randomized phase II/III trial studies how well whole-brain radiation therapy works and compares it with or without hippocampal avoidance in treating patients with small cell lung cancer that is found in one lung, the tissues between the lungs, and nearby lymph nodes only (limited stage) or has spread outside …

serum pregnancy test
metastasis
x-rays
cns metastases
tumor cells
UM Saint Joseph Medical Center
 (9.3 away) Contact site
  • 525 views
  • 07 Jun, 2021
  • +181 other locations
Cisplatin Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery

This randomized phase II trial studies how well temozolomide and capecitabine work compared to standard treatment with cisplatin or carboplatin and etoposide in treating patients with neuroendocrine carcinoma of the gastrointestinal tract or pancreas that has spread to other parts of the body (metastatic) or cannot be removed by surgery. …

Northwest Hospital Center
 (3.8 away) Contact site
  • 701 views
  • 27 Jan, 2021
  • +438 other locations
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

This phase II Pediatric MATCH trial studies how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in deoxyribonucleic acid (DNA) damage repair genes that have spread to other places in the body (advanced) and have come back (relapsed) or do not respond …

graft versus host disease
radiopharmaceutical therapy
international normalized ratio
pegfilgrastim
poly adenosine diphosphate ribose
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 199 views
  • 22 Aug, 2021
  • +74 other locations
tDCS Intervention in Primary Progressive Aphasia

Primary progressive aphasia (PPA) is a neurodegenerative disease that affects first and foremost language abilities. Mild cognitive impairment (MCI) is slowly progressive decline in a single domain of cognition (e.g. language) not attributable to motor or sensory loss, without impediment of social or occupational function. MCI can be an early …

alzheimer's disease
neuropsychological test
cognitive impairment
neurodegenerative disorders
aphasia
Johns Hopkins Hospital
 (9.3 away) Contact site
  • 7 views
  • 20 Apr, 2021
  • 1 location
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

This phase II Pediatric MATCH trial studies how well erdafitinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have spread to other places in the body and have come back or do not respond to treatment with FGFR mutations. Erdafitinib may stop the growth of …

graft versus host disease
radiopharmaceutical therapy
pegfilgrastim
pleural effusions
chemotherapeutic agents
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 261 views
  • 22 Aug, 2021
  • +81 other locations
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

This phase II Pediatric MATCH trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or ROS1 genomic alterations that have come back (recurrent) or do not respond to treatment (refractory) and have spread to other places in the body (advanced). …

graft versus host disease
match treatment
cancer therapy
hematopoietic growth factors
radiopharmaceutical therapy
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 68 views
  • 02 Sep, 2021
  • +76 other locations
A Dose Study of Doxil in a Dose Dense 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

The purpose of this study is to evaluate the feasibility and tolerability of delivering a full dose, on time schedule of dose-dense CDOP-R (cyclophosphamide, doxil, vincristine, prednisone, and rituximab) in NHL.

ejection fraction
b-cell lymphoma
diffuse large b-cell lymphoma
rituximab
pegfilgrastim
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 33 views
  • 07 Nov, 2020
  • 1 location